Ventyx Biosciences, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Ventyx Biosciences, Inc. | VTYX - NASDAQ |
$15.00-$17.00 | $16.00 | $18.65 | 9.5 million | 10/21/2021 |
| Jefferies, Evercore ISI, Piper Sandler | ||||||
Co-Manager(s): LifeSci Capital | ||||||
| Health Care | ||||||
Filing(s): Filed 2021-09-29 Terms Added 2021-10-15 | ||||||
Ventyx Biosciences, Inc. Quote & Chart - Click for current quote - VTYX
IPO Boutique aggregates information on public companies and private companies, such as "VTYX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Ventyx Biosciences, Inc. (adapted from Ventyx Biosciences, Inc. prospectus):
They are a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "VTYX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.